Fig. 2
From: Establishing and validating a new metabolic marker-driven prognosis signature for cutaneous melanoma
Clustering and clinical characterization of MRGs and the immune microenvironment in SKCM samples. (A) Three clusters of MRGs were analyzed using consistent clustering. (B) Differences between the three clusters were analyzed using PCA. (C) KM survival curves indicated significant differences among the three clusters (P < 0.001). (D) Heatmap of MRG clusters correlated with clinical features and gene expression in patientspatients with SKCM. (E) Differences among the three clusters between immune checkpoints and immune cell infiltration in SKCM tumor samples. (F–H) GSVA results indicating pathway enrichment between two distinct clusters.
